Since OT-1 CD8+ T cells were more prone than MH CD8+ T cells to induce antigen-mediated TIRs expression, we tested anti-tumor activity of genetically modified OT-1 CD8+ T cells in B16 melanoma-bearing mice. The gene discussed is CD8A; the disease is melanoma.